Congress Set To Pass Six-Month Funding Bill, As Sequestration Still Looms
This article was originally published in The Gray Sheet
Executive Summary
Both the pending continuing resolution legislation and the sequestration have potential implications, not only for the funding FDA receives from Congress, but also for contributions from industry user fees.
You may also be interested in...
User Fee Limbo: FDA Will Not Have Access To Extra Industry Funds At FY 2013 Start
The new fiscal year starts Oct. 1, but FDA will not be able to spend the full amount of fiscal year 2013 industry user fees as a result of an emergency spending bill, and Congress is not expected to fix the issue until after the election in November at the earliest.
BD's Vince Forlenza Highlights Sequestration Threat To MedTech Research
At a Sept. 20 event in Washington, D.C., Becton Dickinson President and CEO Vince Forlenza said biomedical progress would be undermined by sequestration cuts to the National Institutes of Health. Meanwhile, a new poll shows many Americans oppose cutting medical research.
Sequestration Threat Looms For 2013 Health Care Spending
A report from Sen. Tom Harkin states that impending across-the-board cuts would lead to major NIH grants reduction, in addition to significant spending cuts for cancer and HIV screening.